Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

Technology appraisal guidance
Reference number: TA265
Published: 24 October 2012

Bone metastases from solid tumours - denosumab: appeal from Prostate Cancer Support Federation

Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - appeal received
Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - initial scrutiny letter
Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - response to scrutiny letter
Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - final scrutiny letter

This page was last updated: 18 October 2012